Neuropeptide y gene functional polymorphism influences susceptibility to hypertension in indian population

Journal of Human Hypertension

Volumn 24, Issue 9, 2010, Pages 617-622

  Bhaskar, L V K S ^a,d   Thangaraj, K ^a   Non, A L ^b   Kumar, K Praveen ^a   Pardhasaradhi, G ^a   Singh, L ^a   Rao, V R ^c  

^a CENTRE FOR CELLULAR AND MOLECULAR BIOLOGY   (India)

^b University of Florida ^*  (United States)

^c Anthropological Survey of India   (India)

^d SRI RAMACHANDRA UNIVERSITY   (India)

Author keywords

India; neuropeptide Y; SNP

Indexed keywords

NEUROPEPTIDE Y;

ADULT; ARTICLE; BODY MASS; CONTROLLED STUDY; DIASTOLIC BLOOD PRESSURE; DISEASE PREDISPOSITION; FEMALE; GENE SEQUENCE; GENETIC POLYMORPHISM; GENOTYPE; HUMAN; HYPERTENSION; INDIA; MAJOR CLINICAL STUDY; MALE; SYSTOLIC BLOOD PRESSURE;

ADULT; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HUMANS; HYPERTENSION; INDIA; MALE; MIDDLE AGED; NEUROPEPTIDE Y; POLYMORPHISM, SINGLE NUCLEOTIDE;

EID: 77955926621     PISSN: 09509240     EISSN: 14765527     Source Type: Journal    
DOI: 10.1038/jhh.2009.104     Document Type: Article

References (38)

1. Reddy KS. Hypertension control in developing countries: generic issues. J Hum Hypertens 1996; 10(Suppl 1): S33-S38.
2. Hypertension study group. Prevalence, awareness, treatment and control of hypertension among the elderly in Bangladesh and India: a multicentre study. Bull World Health Organ 2001; 79(6): 490-500.
3. Smith C. Blood pressures of Sherpa men in modernizing Nepal. Am J Hum Biol 1999; 11(4): 469-479.
4. Bevan JA, Brayden JE. Nonadrenergic neural vasodilator mechanisms. Circ Res 1987; 60(3): 309-326.
5. Tatemoto K, Carlquist M, Mutt V. Neuropeptide Y- a novel brain peptide with structural similarities to peptide YY and pancreatic polypeptide. Nature 1982; 296(5858): 659-660.
6. Gray TS, Morley JE. Neuropeptide Y: anatomical distribution and possible function in mammalian nervous system. Life Sci 1986; 38(5): 389-401.
7. OShea D, Morgan DG, Meeran K, Edwards CM, Turton MD, Choi SJ et al. Neuropeptide Y induced feeding in the rat is mediated by a novel receptor. Endocrinology 1997; 138(1): 196-202.
8. Lundberg JM, Terenius L, Hokfelt T, Martling CR, Tatemoto K, Mutt V et al. Neuropeptide Y (NPY)-like immunoreactivity in peripheral noradrenergic neurons and effects of NPY on sympathetic function. Acta Physiol Scand 1982; 116(4): 477-480.
9. Malmstrom RE. Neuropeptide Y Y1 receptor mechanisms in sympathetic vascular control. Acta Physiol Scand Suppl 1997; 636: 1-55.
10. Corr L, Burnstock G, Poole-Wilson P. Effects of age and hyperlipidemia on rabbit coronary responses to neuropeptide Y and the interaction with norepinephrine. Peptides 1993; 14(2): 359-364.
11. Ullman B, Franco-Cereceda A, Hulting J, Lundberg JM, Sollevi A. Elevation of plasma neuropeptide Y-like immunoreactivity and noradrenaline during myocardial ischaemia in man. J Intern Med 1990; 228(6): 583-589.
12. Minth CD, Andrews PC, Dixon JE. Characterization, sequence, and expression of the cloned human neuropeptide Y gene. J Biol Chem 1986; 261(26): 11974-11979.
13. Baker E, Hort YJ, Ball H, Sutherland GR, Shine J, Herzog H. Assignment of the human neuropeptide Y gene to chromosome 7p15.1 by nonisotopic in situ hybridization. Genomics 1995; 26(1): 163-164.
14. Minth CD, Bloom SR, Polak JM, Dixon JE. Cloning, characterization, and DNA sequence of a human cDNA encoding neuropeptide tyrosine. Proc Natl Acad Sci USA 1984; 81(14): 4577-4581.
15. Karvonen MK, Valkonen VP, Lakka TA, Salonen R, Koulu M, Pesonen U et al. Leucine7 to proline7 polymorphism in the preproneuropeptide Y is associated with the progression of carotid atherosclerosis, blood pressure and serum lipids in Finnish men. Atherosclerosis 2001; 159(1): 145-151.
16. Niskanen L, Karvonen MK, Valve R, Koulu M, Pesonen U, Mercuri M et al. Leucine 7 to proline 7 polymorphism in the neuropeptide Y gene is associated with enhanced carotid atherosclerosis in elderly patients with type 2 diabetes and control subjects. J Clin Endocrinol Metab 2000; 85(6): 2266-2269.
17. Karvonen MK, Pesonen U, Koulu M, Niskanen L, Laakso M, Rissanen A et al. Association of a leucine(7)-to-proline(7) polymorphism in the signal peptide of neuropeptide Y with high serum cholesterol and LDL cholesterol levels. Nat Med 1998; 4(12): 1434-1437.
18. Pickering TG. Blood pressure monitoring outside the office for the evaluation of patients with resistant hypertension. Hypertension 1988; 11(3 Pt 2): II96-I100.
19. World Health Organization-International Society of Hypertension Guidelines for the Management of Hypertension. Guidelines Sub-Committee. Blood Press Suppl 1999; 1: 9-43.
20. Thangaraj K, Joshi MB, Reddy AG, Gupta NJ, Chakravarty B, Singh L. CAG repeat expansion in the androgen receptor gene is not associated with male infertility in Indian populations. J Androl 2002; 23(6): 815-818.
21. Cubells JF, Kobayashi K, Nagatsu T, Kidd KK, Kidd JR, Calafell F et al. Population genetics of a functional variant of the dopamine beta-hydroxylase gene (DBH). Am J Med Genet 1997; 74(4): 374-379.
22. Barrett JC, Fry B, Maller J, Daly MJ. Haploview: analysis and visualization of LD and haplotype maps. Bioinformatics 2005; 21(2): 263-265.
23. Tzeng JY, Wang CH, Kao JT, Hsiao CK. Regression-based association analysis with clustered haplotypes through use of genotypes. Am J Hum Genet 2006; 78(2): 231-242.
24. Niskanen L, Voutilainen-Kaunisto R, Terasvirta M, Karvonen MK, Valve R, Pesonen U et al. Leucine 7 to proline 7 polymorphism in the neuropeptide Y gene is associated with retinopathy in type 2 diabetes. Exp Clin Endocrinol Diabetes 2000; 108(3): 235-236.
25. Erkkila AT, Lindi V, Lehto S, Laakso M, Uusitupa MI. Association of leucine 7 to proline 7 polymorphism in the preproneuropeptide Y with serum lipids in patients with coronary heart disease. Mol Genet Metab 2002; 75(3): 260-264.
26. Wallerstedt SM, Skrtic S, Eriksson AL, Ohlsson C, Hedner T. Association analysis of the polymorphism T1128C in the signal peptide of neuropeptide Y in a Swedish hypertensive population. J Hypertens 2004; 22(7): 1277-1281. (Pubitemid 38888072)
27. Yamada Y, Izawa H, Ichihara S, Takatsu F, Ishihara H, Hirayama H et al. Prediction of the risk of myocardial infarction from polymorphisms in candidate genes. N Engl J Med 2002; 347(24): 1916-1923.
28. Drube J, Kawamura N, Nakamura A, Ando T, Komaki G, Inada T. No leucine(7)-to-proline(7) polymorphism in the signal peptide of neuropeptide Y in Japanese population or Japanese with alcoholism. Psychiatr Genet 2001; 11(1): 53-55.
29. Makino K, Kataoka Y, Hirakawa Y, Ikeda A, Yamauchi A, Oishi AR. A leucine(7)-to-proline(7) polymorphism in the signal peptide of neuropeptide Y was not identified in the Japanese population. J Clin Pharm Ther 2001; 26(3): 201-203.
30. Ding B, Bertilsson L, Wahlestedt C. The single nucleotide polymorphism T1128C in the signal peptide of neuropeptide Y (NPY) was not identified in a Korean population. J Clin Pharm Ther 2002; 27(3): 211-212.
31. Jia C, Liu Z, Liu T, Ning Y. The T1128C polymorphism of neuropeptide Y gene in a Chinese population. Arch Med Res 2005; 36(2): 175-177.
32. Duan S, Gao R, Xing Q, Du J, Liu Z, Chen Q et al. A family-based association study of schizophrenia with polymorphisms at three candidate genes. Neurosci Lett 2005; 379(1): 32-36. (Pubitemid 40462393)
33. Bhaskar LV, Thangaraj K, Shah AM, Pardhasaradhi G, Praveen Kumar K, Reddy AG et al. Allelic variation in the NPY gene in 14 Indian populations. J Hum Genet 2007; 52(7): 592-598.
34. Pesonen U. NPY L7P polymorphism and metabolic diseases. Regul Pept 2008; 149(1-3): 51-55.
35. Mitchell GC, Wang Q, Ramamoorthy P, Whim MD. A common single nucleotide polymorphism alters the synthesis and secretion of neuropeptide Y. J Neurosci 2008; 28(53): 14428-14434.
36. Komaru T, Ashikawa K, Kanatsuka H, Sekiguchi N, Suzuki T, Takishima T. Neuropeptide Y modulates vasoconstriction in coronary microvessels in the beating canine heart. Circ Res 1990; 67(5): 1142-1151.
37. Solt VB, Brown MR, Kennedy B, Kolterman OG, Ziegler MG. Elevated insulin, norepinephrine, and neuropeptide Y in hypertension. Am J Hypertens 1990; 3(11): 823-828.
38. Michalkiewicz M, Michalkiewicz T, Kreulen DL, McDougall SJ. Increased blood pressure responses in neuropeptide Y transgenic rats. Am J Physiol Regul Integr Comp Physiol 2001; 281(2): R417-R426.